European Approval Sought for Amivantamab Plus Chemo in EGFR Exon 20 Insertion+ NSCLC

October 6, 2023Kristi RosaA Type II extension of indication application seeking the approval of amivantamab in combination with carboplatin and pemetrexed for the frontline treatment of adult patients

Updated on: October 09,2023 181

European Approval Sought for Amivantamab Plus Chemo in EGFR Exon 20 Insertion+ NSCLC

October 6, 2023Kristi RosaA Type II extension of indication application seeking the approval of amivantamab in combination with carboplatin and pemetrexed for the frontline treatment of adult patients

Updated on:October 09,2023 181

How Successful Is Immunotherapy for Breast Cancer?

ByMaxine LipnerPublished on August 18, 2023Medically reviewed byDoru Paul, MDImmunotherapycan boost your body's immune response to cancer cells and hopefully kill the

Updated on: November 20,2023 231

How Successful Is Immunotherapy for Breast Cancer?

ByMaxine LipnerPublished on August 18, 2023Medically reviewed byDoru Paul, MDImmunotherapycan boost your body's immune response to cancer cells and hopefully kill the

Updated on:November 20,2023 231

What Causes Blood in Vomit?

What Causes Blood in Vomit?ByPatty Weasler, RN, BSNPublished on October 28, 2022Medically reviewed byJay N. Yepuri, MD"Hematemesis"is the medical term for vomit

Updated on: March 17,2024 0

What Causes Blood in Vomit?

What Causes Blood in Vomit?ByPatty Weasler, RN, BSNPublished on October 28, 2022Medically reviewed byJay N. Yepuri, MD"Hematemesis"is the medical term for vomit

Updated on:March 17,2024 0

New potential therapeutic approach for HER2-positive breast cancer discovered

by Leibniz Research Centre for Working Environments and Human Factors in DortmundEDI3 expression and enzyme activity according to HER2 and ER status. A, EDI3 (GPCPD1; 224826_at) mRNA expression was co

Updated on: December 21,2023 14

New potential therapeutic approach for HER2-positive breast cancer discovered

by Leibniz Research Centre for Working Environments and Human Factors in DortmundEDI3 expression and enzyme activity according to HER2 and ER status. A, EDI3 (GPCPD1; 224826_at) mRNA expression was co

Updated on:December 21,2023 14

Gene linked to glioblastoma stem cell self-renewal and immunosuppression

by Olivia Dimmer,Northwestern UniversityWorking model. a, Illustration shows a proposed mechanism for the TFPI2 and its associated signaling axis in regulating self-renewal of glioma stem cells

Updated on: October 31,2023 5

Gene linked to glioblastoma stem cell self-renewal and immunosuppression

by Olivia Dimmer,Northwestern UniversityWorking model. a, Illustration shows a proposed mechanism for the TFPI2 and its associated signaling axis in regulating self-renewal of glioma stem cells

Updated on:October 31,2023 5

Cancer survivor feared recurrence, but this time it was his heart

Heart attack survivor Doug Cobb. Photo: Caitriona CobbDoug Cobb popped a couple antacid pills to calm the heartburn he'd been experiencing on and off for weeks. The 60-year-old considered he might

Updated on: December 10,2023 8

Cancer survivor feared recurrence, but this time it was his heart

Heart attack survivor Doug Cobb. Photo: Caitriona CobbDoug Cobb popped a couple antacid pills to calm the heartburn he'd been experiencing on and off for weeks. The 60-year-old considered he might

Updated on:December 10,2023 8

Skin cancer: More people die from types that aren't melanoma, says surprise new finding

by Sarah Allinson,The ConversationCredit: AI-generated imageIf you mention skin cancer, most people think of melanoma—the deadliest skin cancer. The other ones are pretty benign, right?Not so. W

Updated on: October 31,2023 8

Skin cancer: More people die from types that aren't melanoma, says surprise new finding

by Sarah Allinson,The ConversationCredit: AI-generated imageIf you mention skin cancer, most people think of melanoma—the deadliest skin cancer. The other ones are pretty benign, right?Not so. W

Updated on:October 31,2023 8

EMA Grants PRIME Designation to Iopofosine I-131 for Waldenström Macroglobulinemia

September 18, 2023Kristi RosaThe European Medicines Agency has granted Priority Medicines designation to iopofosine I-131 for use in patients with Waldenström macroglobulinemia in patients who previou

Updated on: October 11,2023 148

EMA Grants PRIME Designation to Iopofosine I-131 for Waldenström Macroglobulinemia

September 18, 2023Kristi RosaThe European Medicines Agency has granted Priority Medicines designation to iopofosine I-131 for use in patients with Waldenström macroglobulinemia in patients who previou

Updated on:October 11,2023 148

Success of Rhabdomyosarcoma Treatment in Children

Including Rarer Types of RMS Disease in AdultsByJaime R. Herndon, MS, MPHPublished on July 03, 2023Medically reviewed byDoru Paul, MDRhabdomyosarcomais a kind ofsar

Updated on: November 21,2023 56

Success of Rhabdomyosarcoma Treatment in Children

Including Rarer Types of RMS Disease in AdultsByJaime R. Herndon, MS, MPHPublished on July 03, 2023Medically reviewed byDoru Paul, MDRhabdomyosarcomais a kind ofsar

Updated on:November 21,2023 56

Who Gets Laryngeal (Voice Box) Cancer?

Dysplasia means precancerous, which isn’t cancer yet, but it could progressByAnna GiorgiPublished on July 24, 2023Medically reviewed byBenjamin F. Asher, MDLaryngeal cancer, al

Updated on: November 21,2023 192

Who Gets Laryngeal (Voice Box) Cancer?

Dysplasia means precancerous, which isn’t cancer yet, but it could progressByAnna GiorgiPublished on July 24, 2023Medically reviewed byBenjamin F. Asher, MDLaryngeal cancer, al

Updated on:November 21,2023 192

New study disentangles a long-standing link between inflammation and cancer progression

byUniversity of OxfordCredit: AI-generated imageA new study published inNature Geneticsled by the Mead Group in the Radcliffe Department of Medicine has demonstrated a previously unk

Updated on: October 31,2023 5

New study disentangles a long-standing link between inflammation and cancer progression

byUniversity of OxfordCredit: AI-generated imageA new study published inNature Geneticsled by the Mead Group in the Radcliffe Department of Medicine has demonstrated a previously unk

Updated on:October 31,2023 5

Cell: Tumor lysis therapy 'porks' cancer cells to fight cancer

Not long ago, by a team of researchers, published a heavy research paper in the top journal “Cell”, which opens a new way of thinking for cancer treatment.

Updated on: March 18,2025 0

Cell: Tumor lysis therapy 'porks' cancer cells to fight cancer

Not long ago, by a team of researchers, published a heavy research paper in the top journal “Cell”, which opens a new way of thinking for cancer treatment.

Updated on:March 18,2025 0